Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.64 |
| ▸ | CES1 | P23141 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.61 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | GSK3B | P49841 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Picolinic Acid SCHEMBL30414202 | 1.00 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL11378795 | 0.98 | CES2 (0.67) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL673572 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL15271681 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL11378797 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL5354659 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL6054281 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL5058098 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL524041 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL432467 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9468645-B2 | Highly soluble purine bioactive compounds and compositions thereof | ENERGY BEVERAGES LLC | 2016-10-18 | — | — | US | disclosed |
| US-20150238494-A1 | HIGHLY SOLUBLE PURINE BIOACTIVE COMPOUNDS AND COMPOSITIONS THEREOF | ENERGY BEVERAGES LLC | 2015-08-27 | — | — | US | disclosed |
| US-20150132440-A1 | DIPEPTIDE AND TRIPEPTIDE COMPOSITIONS AND USES | JHO INTELLECTUAL PROPERTY HOLDINGS, LLC | 2015-05-14 | — | — | US | disclosed |
| US-20150050260-A1 | PYRROLOQUINOLINE QUINONE BASED COMPOSITIONS AND USES | JHO INTELLECTUAL PROPERTY HOLDINGS, LLC | 2015-02-19 | — | — | US | disclosed |
| US-8445466-B2 | Stable aqueous compositions comprising amide-protected bioactive creatine species and uses thereof | ENERGY BEVERAGES LLC | 2013-05-21 | — | — | US | disclosed |
| EP-2377578-A1 | Stable aqueous compositions comprising amide-protected bioactive creatine species and uses thereof | Owoc, John H. (US) | 2011-10-19 | — | — | EP | disclosed |
| US-20110251280-A1 | Stable Aqueous Compositions Comprising Amide-Protected Bioactive Creatine Species and Uses Thereof | ENERGY BEVERAGES LLC | 2011-10-13 | — | — | US | disclosed |
| US-4731124-A | Application technique for the descaling of surfaces | CENTRAL ELECTRICITY GENERATING BOARD (GB) | 1988-03-15 | — | — | US | disclosed |
| EP-0046029-B1 | AN APPLICATION TECHNIQUE FOR THE DESCALING OF SURFACES | CENTRAL ELECTRICITY GENERATING BOARD (GB) | 1984-10-03 | — | — | EP | disclosed |
| US-4470951-A | Application technique for the descaling of surfaces | CENTRAL ELECTRICITY GENERATING BOARD (GB) | 1984-09-11 | — | — | US | disclosed |
| EP-0046029-A1 | An application technique for the descaling of surfaces | CENTRAL ELECTRICITY GENERATING BOARD (GB) | 1982-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251280-A1 | Stable Aqueous Compositions Comprising Amide-Protected Bioactive Creatine Species and Uses Thereof | REN, CKMT1A; CKMT1B, GLS | CES2 655/4885CES1 168/4885L3MBTL1 4591/4885 |
| US-20150238494-A1 | HIGHLY SOLUBLE PURINE BIOACTIVE COMPOUNDS AND COMPOSITIONS THEREOF | ADORA2A, PNP, P2RX6 | CES2 4668/4885CES1 3413/4885L3MBTL1 4314/4885 |
| US-20150050260-A1 | PYRROLOQUINOLINE QUINONE BASED COMPOSITIONS AND USES | NQO1, NDUFB5, SDHA | CES2 2371/4885CES1 1769/4885L3MBTL1 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.